Semaglutide is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Semaglutide is administered via subcutaneous injection or oral at 0.25-2.4 mg weekly (injection) or 3-14 mg daily (oral) once weekly (injection) or daily (oral). Subcutaneous injections into the abdominal fat or thigh are most common. Proper reconstitution with bacteriostatic water is required first.
How Do You Inject Semaglutide?
Semaglutide is administered via subcutaneous injection or oral. For most researchers, subcutaneous injection is the standard approach — it's simple, relatively painless, and effective for GLP-1 receptor agonist incretin mimetic compounds.
This guide covers injection technique, site selection, needle choices, and common mistakes.
How Do You Prepare for a Semaglutide Injection?
Step 1: Wash your hands thoroughly.
Step 2: Clean the top of the Semaglutide vial and BAC water vial with alcohol swabs. If not yet reconstituted, see our Semaglutide reconstitution guide.
Step 3: Draw your dose (0.25-2.4 mg weekly (injection) or 3-14 mg daily (oral)) into an insulin syringe. Use our calculator for exact units.
Step 4: Clean the injection site with an alcohol swab and let it dry.
What Is the Correct Injection Technique?
Subcutaneous (most common): Pinch a fold of skin — typically abdominal fat 2+ inches from the navel, or the thigh. Insert the needle at a 45-degree angle. Push the plunger slowly and steadily. Hold for 5 seconds, then withdraw.
Intramuscular (less common for Semaglutide): Insert the needle at 90 degrees into the muscle (deltoid or vastus lateralis). This route provides faster absorption but isn't necessary for most peptide protocols.
Rotate injection sites to prevent lipodystrophy (fat tissue changes from repeated injections in the same spot).
What Size Needle Should You Use?
For subcutaneous Semaglutide injections, 29-31 gauge insulin needles (½ inch or 8mm) are standard. These are thin enough to be nearly painless while long enough for proper subcutaneous delivery.
Use a fresh needle for every injection. Never reuse or share needles.
Calculate Your Semaglutide Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Semaglutide.
Open Calculator →What Are Common Injection Side Effects?
Mild redness, swelling, or itching at the injection site is normal and typically resolves within hours. Small bruises can occur, especially if you hit a capillary.
If you experience persistent pain, swelling, warmth, or redness lasting more than 24 hours, discontinue and consult a healthcare provider — these may indicate infection.
Bottom Line on Semaglutide Injection
Semaglutide is administered via subcutaneous injection or oral at 0.25-2.4 mg weekly (injection) or 3-14 mg daily (oral) once weekly (injection) or daily (oral). Subcutaneous injection with a 29-31 gauge insulin needle into abdominal fat is the standard technique. Rotate sites and use a fresh needle every time.
Complete Guide
Semaglutide : Benefits, Dosage, Side Effects & Research
Related Reading
- Semaglutide Dosage Guide
- Semaglutide Benefits
- Semaglutide Side Effects
- Semaglutide Stacking Guide
- Semaglutide Cycle Guide
- Semaglutide Research
Research-Grade Sourcing
If you're going to research Semaglutide, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Semaglutide?
Semaglutide (Semaglutide (GLP-1 receptor agonist)) is a GLP-1 receptor agonist incretin mimetic. Synthetic GLP-1 analog developed by Novo Nordisk with amino acid modifications for extended half-life. It is researched for weight loss (16-22.5%), glycemic control, cardiovascular event reduction, appetite suppression.
What is the recommended Semaglutide dosage?
Common dosages: 0.25-2.4 mg weekly (injection) or 3-14 mg daily (oral) administered once weekly (injection) or daily (oral) via subcutaneous injection or oral. Cycle length: ongoing, titrated over 4-5 weeks. Half-life: 7 days. Use our peptide calculator for exact reconstitution math.
What are the side effects of Semaglutide?
Nausea, vomiting, diarrhea (20-40% incidence, decreasing over 4-8 weeks). Thyroid C-cell tumor risk in rodents (human relevance unclear). Rare pancreatitis and diabetic retinopathy worsening.
Is Semaglutide safe?
Semaglutide has shown a preliminary safety profile in research. FDA-approved for type 2 diabetes (Ozempic), weight management (Wegovy), and chronic kidney disease. Prescription medication. All research should follow appropriate safety protocols.